Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products

The purpose of this work is to explore the predictive ability of the biopharmaceutics classification system (BCS) biowaiver based on the dissolution methods for two pravastatin test products, where one of them showed bioequivalence (BE) while the other test failed (non-bioequivalence, or NBE), and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Picazo, Alejandro, Colón-Useche, Sarin, Perez-Amorós, Blanca, González-Álvarez, Marta, Molina-Martínez, Irene, González-Álvarez, Isabel, García-Arieta, Alfredo, Bermejo, Marival
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956045/
https://www.ncbi.nlm.nih.gov/pubmed/31835294
http://dx.doi.org/10.3390/pharmaceutics11120663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956045/
https://www.ncbi.nlm.nih.gov/pubmed/31835294
http://dx.doi.org/10.3390/pharmaceutics11120663

Ejemplares similares